CoChat
Sign Up
Cited by 10

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Role of Membrane Lipid Rafts in MRP4 (ABCC4) Dependent Regulation of the cAMP Pathway in Blood Platelets

Belleville-Rolland, Tiphaine, Leuci, Alexandre, Mansour, Alexandre, Decouture, Benoit, Martin, Fanny, Poirault-Chassac, Sonia, Rouaud, Margot, Guerineau, Hippolyte, Dizier, Blandine, Pidard, Dominique, Gaussem, Pascale, Bachelot-Loza, Christilla·2021·Thrombosis and Haemostasis
DOI 10.1055/a-1481-2663
Open this paper in CoChat — free account

Abstract

Background Platelet cytosolic cyclic adenosine monophosphate (cAMP) levels are balanced by synthesis, degradation, and efflux. Efflux can occur via multidrug resistant protein-4 (MRP4; ABCC4) present on dense granule and/or plasma membranes. As lipid rafts have been shown to interfere on cAMP homeostasis, we evaluated the relationships between the distribution and activity of MRP4 in lipid rafts and cAMP efflux. Methods Platelet activation and cAMP homeostasis were analyzed in human and wild-type or MRP4-deleted mouse platelets in the presence of methyl-β-cyclodextrin (MßCD) to disrupt lipid rafts, and of activators of the cAMP signalling pathways. Human platelet MRP4 and effector proteins of the cAMP pathway were analyzed by immunoblots in lipid rafts isolated by differential centrifugation. Results MßCD dose dependently inhibited human and mouse platelet aggregation without affecting per se cAMP levels. An additive inhibitory effect existed between the adenylate cyclase (AC) activator forskolin and MßCD that was accompanied by an overincrease of cAMP, and which was significantly enhanced upon MRP4 deletion. Finally, an efflux of cAMP out of resting platelets incubated with prostaglandin E1 (PGE1) was observed that was partly dependent on MRP4. Lipid rafts contained a small fraction (≈15%) of MRP4 and most of the inhibitory G-protein Gi, whereas Gs protein, AC3, and phosphodiesterases PDE2 and PDE3A were all present as only trace amounts. Conclusion Our results are in favour of part of MRP4 present at the platelet surface, including in lipid rafts. Lipid raft integrity is necessary for cAMP signalling regulation, although MRP4 and most players of cAMP homeostasis are essentially located outside rafts.

Overview

Integrity signals

Registry

Crossref · 10.1055/a-1481-2663

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 41

  1. A Smolenski, 2012, Novel roles of cAMP/cGMP-dependent signaling in platelets, J Thromb Haemost, 10, 167, 10.1111/j.1538-7836.2011.04576.x · DOI
  2. A Marcus, 2001, Thromboregulation by endothelial cells: significance for occlusive vascular diseases, Arterioscler Thromb Vasc Biol, 21, 178, 10.1161/01.ATV.21.2.178 · DOI
  3. S Narumiya, 1999, Prostanoid receptors: structures, properties, and functions, Physiol Rev, 79, 1193, 10.1152/physrev.1999.79.4.1193 · DOI
  4. J M Burkhart, 2012, The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways, Blood, 120, e73, 10.1182/blood-2012-04-416594 · DOI
  5. S Makhoul, 2018, Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets, Nitric Oxide, 76, 71, 10.1016/j.niox.2018.03.008 · DOI
  6. K Taskén, 2004, Localized effects of cAMP mediated by distinct routes of protein kinase A, Physiol Rev, 84, 137, 10.1152/physrev.00021.2003 · DOI
  7. Z Nagy, 2018, Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses, Res Pract Thromb Haemost, 2, 558, 10.1002/rth2.12122 · DOI
  8. R W Hunter, 2009, Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets, J Biol Chem, 284, 12339, 10.1074/jbc.M807536200 · DOI
  9. S D Stroop, 1991, Structure and function studies of the cGMP-stimulated phosphodiesterase, J Biol Chem, 266, 23802, 10.1016/S0021-9258(18)54354-4 · DOI
  10. I V Turko, 1998, Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation, Biochem J, 329, 505, 10.1042/bj3290505 · DOI
  11. B Hechler, 2011, P2 receptors and platelet function, Purinergic Signal, 7, 293, 10.1007/s11302-011-9247-6 · DOI
  12. P A Gurbel, 2010, Combination antithrombotic therapies, Circulation, 121, 569, 10.1161/CIRCULATIONAHA.109.853085 · DOI
  13. P Gresele, 2011, Anti-platelet therapy: phosphodiesterase inhibitors, Br J Clin Pharmacol, 72, 634, 10.1111/j.1365-2125.2011.04034.x · DOI
  14. T Belleville-Rolland, 2016, MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease, Pharmacol Res, 107, 381, 10.1016/j.phrs.2016.04.002 · DOI
  15. S B Cheepala, 2015, The ABCC4 membrane transporter modulates platelet aggregation, Blood, 126, 2307, 10.1182/blood-2014-08-595942 · DOI
  16. F G Russel, 2008, Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules, Trends Pharmacol Sci, 29, 200, 10.1016/j.tips.2008.01.006 · DOI · Paper page
  17. Y Sassi, 2012, Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes, FASEB J, 26, 1009, 10.1096/fj.11-194027 · DOI
  18. A Borgognone, 2012, Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport, Thromb Haemost, 108, 955, 10.1160/TH12-04-0232 · DOI
  19. B Decouture, 2015, Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice, Blood, 126, 1823, 10.1182/blood-2015-02-631044 · DOI
  20. G Jedlitschky, 2004, The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage, Blood, 104, 3603, 10.1182/blood-2003-12-4330 · DOI
  21. G Jedlitschky, 2010, Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies, Am J Pathol, 176, 1097, 10.2353/ajpath.2010.090425 · DOI
  22. T Mattiello, 2011, Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting, J Am Coll Cardiol, 58, 752, 10.1016/j.jacc.2011.03.049 · DOI
  23. H V Edwards, 2012, cAMP: novel concepts in compartmentalised signalling, Semin Cell Dev Biol, 23, 181, 10.1016/j.semcdb.2011.09.005 · DOI
  24. R Fischmeister, 2006, Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases, Circ Res, 99, 816, 10.1161/01.RES.0000246118.98832.04 · DOI
  25. M Zaccolo, 2002, Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes, Science, 295, 1711, 10.1126/science.1069982 · DOI
  26. J L Esseltine, 2013, AKAP signaling complexes: pointing towards the next generation of therapeutic targets?, Trends Pharmacol Sci, 34, 648, 10.1016/j.tips.2013.10.005 · DOI
  27. Z Raslan, 2015, Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3′,5′-cyclic adenosine monophosphate-signaling pathway, J Thromb Haemost, 13, 1721, 10.1111/jth.13042 · DOI
  28. S Bodin, 2003, Lipid rafts are critical membrane domains in blood platelet activation processes, Biochim Biophys Acta, 1610, 247, 10.1016/S0005-2736(03)00022-1 · DOI
  29. E Sezgin, 2017, The mystery of membrane organization: composition, regulation and roles of lipid rafts, Nat Rev Mol Cell Biol, 18, 361, 10.1038/nrm.2017.16 · DOI · Paper page
  30. Z Raslan, 2015, Compartmentalisation of cAMP-dependent signalling in blood platelets: The role of lipid rafts and actin polymerisation, Platelets, 26, 349, 10.3109/09537104.2014.916792 · DOI
  31. W Zhang, 1998, LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation, Immunity, 9, 239, 10.1016/S1074-7613(00)80606-8 · DOI
  32. P Wonerow, 2002, Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets, Biochem J, 364, 755, 10.1042/bj20020128 · DOI
  33. V Rabani, 2016, Comparative lipidomics and proteomics analysis of platelet lipid rafts using different detergents, Platelets, 27, 634, 10.3109/09537104.2016.1174203 · DOI
  34. V O Nikolaev, 2010, Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation, Science, 327, 1653, 10.1126/science.1185988 · DOI
  35. R Zidovetzki, 2007, Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies, Biochim Biophys Acta, 1768, 1311, 10.1016/j.bbamem.2007.03.026 · DOI
  36. K Gousset, 2002, Evidence for a physiological role for membrane rafts in human platelets, J Cell Physiol, 190, 117, 10.1002/jcp.10039 · DOI
  37. T M Quinton, 2005, Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation, J Thromb Haemost, 3, 1036, 10.1111/j.1538-7836.2005.01325.x · DOI
  38. Z Raslan, 2015, The spatiotemporal regulation of cAMP signaling in blood platelets—old friends and new players, Front Pharmacol, 6, 266, 10.3389/fphar.2015.00266 · DOI
  39. D Mika, 2012, PDEs create local domains of cAMP signaling, J Mol Cell Cardiol, 52, 323, 10.1016/j.yjmcc.2011.08.016 · DOI
  40. S F Steinberg, 2001, Compartmentation of G protein-coupled signaling pathways in cardiac myocytes, Annu Rev Pharmacol Toxicol, 41, 751, 10.1146/annurev.pharmtox.41.1.751 · DOI
  41. P P Burgers, 2012, A small novel A-kinase anchoring protein (AKAP) that localizes specifically protein kinase A-regulatory subunit I (PKA-RI) to the plasma membrane, J Biol Chem, 287, 43789, 10.1074/jbc.M112.395970 · DOI

Cited by

Sorted by citations

See all 10

Metadata

Authors
Belleville-Rolland, T., Leuci, A., Mansour, A., Decouture, B., Martin, F., Poirault-Chassac, S., Rouaud, M., Guerineau, H., Dizier, B., Pidard, D., Gaussem, P., & Bachelot-Loza, C.
Venue
Thrombosis and Haemostasis
Publisher
Georg Thieme Verlag KG
Published
2021-04-13
Volume
121
Issue
12
Pages
1628-1636
ISSN
  • 0340-6245
  • 2567-689X
DOI
10.1055/a-1481-2663
Cited by
10
References
1
Language
en
Funders
Institut National de la Santé et de la Recherche Médicale, Promex Stiftung für die Forschung Foundation, Université de Paris

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review